{"id":"W3208988466","doi":"10.1007/s40744-021-00388-8","title":"Ixekizumab Demonstrates Consistent Efficacy Versus Adalimumab in Biologic Disease-Modifying Anti-rheumatic Drug-Naïve Psoriatic Arthritis Patients Regardless of Psoriasis Severity: 52-Week Post Hoc Results from SPIRIT-H2H","year":2021,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Adalimumab; Psoriatic arthritis; Psoriasis; Post-hoc analysis; Dermatology; Drug; Arthritis; Pharmacology; Internal medicine; Disease; Secukinumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006466179,0.001854954,0.004038467,0.0004673323,0.0003752886,0.00109299,0.001070503,0.00104149,0.00479745],"category_scores_gemma":[0.003771855,0.0007632505,0.004011163,0.0003693149,0.001209862,0.001100584,0.0007359315,0.002789369,0.0007496168],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007905546,"about_ca_system_score_gemma":0.001517078,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008415415,"about_ca_topic_score_gemma":0.001723353,"domain_scores_codex":[0.9971882,0.001650728,0.0001920419,0.0004077974,0.0002018588,0.0003593999],"domain_scores_gemma":[0.9963225,0.001104906,0.0008664784,0.0006740725,0.0003015461,0.0007305677],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9698693,0.0139021,0.001099443,0.0001809706,0.001286053,0.00001941209,0.00005699979,0.0004215323,0.005851224,0.00002302848,0.000445015,0.006845042],"study_design_scores_gemma":[0.5396196,0.4400101,0.01353468,0.00001845242,0.001739645,0.00004294778,0.00004689485,0.001000779,0.003352423,0.00008802988,0.0005097308,0.00003683126],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971656,0.0004002408,0.0002841072,0.0001155557,0.0001077799,0.0006903393,0.0007118768,0.00005097143,0.0004734453],"genre_scores_gemma":[0.9944389,0.0003176364,0.001046578,0.0002431413,0.0003104859,0.0009166831,0.001469434,0.00003757512,0.001219584],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006466179,"threshold_uncertainty_score":0.03419685,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02560367786290212,"score_gpt":0.2640450770393959,"score_spread":0.2384413991764938,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}